Skip to main content

Table 1 Current UK vaccination against invasive meningococcal disease

From: The “Petechiae in children” (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA – a study protocol

Current UK Vaccination Against Invasive Meningococcal Disease

Vaccine (Serogroups)

Year Introduced into schedule

Age given

B

2015

8 weeks, 16 weeks, 1 year

C

1999

1 yeara

ACWY

2015

14 years, University students 19–25 years

  1. aPrior to 2016 meningococcal C vaccine was also administered at 12 weeks